A new prognostic biomarker for metastatic Colorectal Cancer (mCRC)

    Seal Biosciences Inc. is a Diagnostic company founded by scientists at UCSF. Our founding technology is based on the discovery of a potential prognostic cancer biomarker – RASGRP1 – which is a member of the Epidermal Growth Factor signaling pathway and confers a significant tumor-suppressive effect.